Keller Eric L. Insider Trades & Stock Holdings

CHIEF EXECUTIVE OFFICER · Retension Pharmaceuticals, Inc. · Latest filing Oct 13, 2026

Keller Eric L., CHIEF EXECUTIVE OFFICER at Retension Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 13, 2026. Open-market activity: 1 purchase ($249.60K) and 0 sales ($0), net +$249.60K. Latest filing: acquired 20.80K shares of $RTSN on Oct 13, 2026 at $12.

Trades on file

1

Open-market bought

$249.60K

Open-market sold

$0

Net open-market

+$249.60K

Latest filing

Oct 13, 2026

All insider trades by Keller Eric L.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 13, 2026	$RTSN	Buy (Open-market buy)	20.80K	$12	$249.60K						CHIEF EXECUTIVE OFFICER		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Keller Eric L. traded

• $RTSN

Frequently asked questions

Has Keller Eric L. been buying or selling stock?

Keller Eric L. has 1 open-market purchase and 0 open-market sales on file, net +$249.60K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Keller Eric L.'s latest insider trade?

acquired 20.80K shares of $RTSN on Oct 13, 2026 at $12.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.